• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎中的淋巴细胞减少症:治疗机会。

Lymphopenia in COVID-19: Therapeutic opportunities.

机构信息

Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

出版信息

Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3.

DOI:10.1002/cbin.11403
PMID:32458561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7283672/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncontrollably spread all over the world. The host immune responses strongly try to confront it with all the potential cells and cytokines. With chronically condition of SARS-CoV-2, natural killer cells and T cells become exhausted and decreasing their count leads to lymphopenia. Inability to eradicate the infected organ makes hyperinitiation of the immune system, which releases the excessive inflammatory cytokines to compensate the exhausted one as well as the low lymphocytes counts; it consequently leads to the cytokine storm syndrome. These mechanisms and the potential therapeutic targeting are discussed in this paper.

摘要

严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2)在全球范围内失控传播。宿主的免疫反应会极力调动所有潜在的细胞和细胞因子与之对抗。在 SARS-CoV-2 慢性感染的情况下,自然杀伤细胞和 T 细胞耗竭,数量减少导致淋巴细胞减少症。由于无法清除受感染的器官,免疫系统过度启动,释放过多的炎症细胞因子来弥补耗竭的细胞因子和低淋巴细胞计数;从而导致细胞因子风暴综合征。本文讨论了这些机制和潜在的治疗靶点。

相似文献

1
Lymphopenia in COVID-19: Therapeutic opportunities.新型冠状病毒肺炎中的淋巴细胞减少症:治疗机会。
Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3.
2
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).白细胞介素 7 免疫疗法与重症 2019 冠状病毒病(COVID-19)患者淋巴细胞计数的关联。
JAMA Netw Open. 2020 Jul 1;3(7):e2016485. doi: 10.1001/jamanetworkopen.2020.16485.
3
Host-directed therapies: a potential solution to combat COVID-19.宿主导向疗法:对抗新冠病毒病的一种潜在解决方案。
Expert Opin Biol Ther. 2020 Oct;20(10):1117-1120. doi: 10.1080/14712598.2020.1807001. Epub 2020 Aug 12.
4
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.2019年冠状病毒病的免疫学特征:T细胞功能耗竭与细胞因子风暴
J Clin Immunol. 2020 Oct;40(7):974-976. doi: 10.1007/s10875-020-00824-4. Epub 2020 Jul 10.
5
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.新冠病毒中极其激进的网络:氧化应激、中性粒细胞胞外陷阱(NETs)和T细胞抑制。
Adv Biol Regul. 2020 Aug;77:100741. doi: 10.1016/j.jbior.2020.100741. Epub 2020 Jul 4.
6
Cell-Free Therapies: Novel Approaches for COVID-19.无细胞疗法:治疗新冠肺炎的新方法。
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
7
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
8
Perforin and resistance to SARS coronavirus 2.穿孔素与对严重急性呼吸综合征冠状病毒2的抵抗力
J Allergy Clin Immunol. 2020 Jul;146(1):52-53. doi: 10.1016/j.jaci.2020.05.007. Epub 2020 May 15.
9
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.免疫反应重置作为克服 SARS-CoV-2 诱导的细胞因子风暴的一种新策略。
J Immunol. 2020 Nov 15;205(10):2566-2575. doi: 10.4049/jimmunol.2000892. Epub 2020 Sep 21.
10
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑:免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.

引用本文的文献

1
Severity-specific immune landscape of COVID-19 revealed by single-cell sequencing.单细胞测序揭示的COVID-19严重程度特异性免疫图谱
Sci Rep. 2025 Aug 12;15(1):29596. doi: 10.1038/s41598-025-13888-2.
2
An Epidemic of Parvovirus B19-Induced Aplastic Crises in Pediatric Patients with Hereditary Spherocytosis Following the COVID-19 Pandemic: A Single-Center Retrospective Study.COVID-19大流行后遗传性球形红细胞增多症患儿中B19微小病毒引起的再生障碍危象流行:一项单中心回顾性研究
Children (Basel). 2025 Jun 13;12(6):772. doi: 10.3390/children12060772.
3
Leukocyte telomere length and telomerase activity in Long COVID patients from Rio de Janeiro, Brazil.巴西里约热内卢新冠长期症状患者的白细胞端粒长度和端粒酶活性
Mem Inst Oswaldo Cruz. 2025 Apr 11;120:e240129. doi: 10.1590/0074-02760240129. eCollection 2025.
4
Hemoperfusion Combined With Continuous Renal Replacement Therapy in the Management of ARDS COVID-19 Patients: A Quasi-Experimental Study.血液灌流联合连续性肾脏替代疗法治疗新型冠状病毒肺炎急性呼吸窘迫综合征患者:一项准实验研究
Health Sci Rep. 2025 Apr 1;8(4):e70571. doi: 10.1002/hsr2.70571. eCollection 2025 Apr.
5
Early lymphopenia as a predictor of COVID-19 outcomes: A multicenter cohort study.早期淋巴细胞减少作为COVID-19预后的预测指标:一项多中心队列研究。
Acute Med Surg. 2025 Mar 21;12(1):e70044. doi: 10.1002/ams2.70044. eCollection 2025 Jan-Dec.
6
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial.短暂性淋巴细胞计数减少与溶瘤腺病毒在人体中的疗效相关:TUNIMO I期试验的机制和生物标志物研究结果
J Immunother Cancer. 2025 Jan 27;13(1):e010493. doi: 10.1136/jitc-2024-010493.
7
Medicinal plants for the management of post-COVID-19 fatigue: A literature review on the role and mechanisms.用于管理新冠后疲劳的药用植物:关于作用及机制的文献综述
J Tradit Complement Med. 2024 May 23;15(1):15-23. doi: 10.1016/j.jtcme.2024.05.006. eCollection 2025 Jan.
8
Prevalence of lymphopenia in the American population: Insights from demographic, BMI, and lifestyle factors.美国人群中淋巴细胞减少症的流行情况:来自人口统计学、BMI 和生活方式因素的见解。
PLoS One. 2024 Nov 4;19(11):e0312540. doi: 10.1371/journal.pone.0312540. eCollection 2024.
9
Utilizing press needle acupuncture to treat mild-to-moderate COVID-19: A single-blind, randomized controlled trial.利用按压针针刺治疗轻至中度 COVID-19:一项单盲、随机对照试验。
Medicine (Baltimore). 2024 Oct 4;103(40):e39810. doi: 10.1097/MD.0000000000039810.
10
Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action.儿科心理健康保健在 COVID-19 大流行期间:呼吁国际公共卫生行动。
Adv Exp Med Biol. 2024;1458:19-34. doi: 10.1007/978-3-031-61943-4_2.

本文引用的文献

1
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病(COVID-19)患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
2
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.针对 COVID-19 的治疗规划:使用多种免疫抑制剂的原理和假设:抗抗体、免疫球蛋白和皮质类固醇。
Int Immunopharmacol. 2020 Jul;84:106560. doi: 10.1016/j.intimp.2020.106560. Epub 2020 May 8.
3
COVID-19: Developing from an Outbreak to A Pandemic.新型冠状病毒肺炎:从疫情爆发到全球大流行
Arch Med Res. 2020 Aug;51(6):582-584. doi: 10.1016/j.arcmed.2020.04.021. Epub 2020 May 13.
4
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
5
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.患者康复前伴随免疫反应的广度:非重症COVID-19病例报告
Nat Med. 2020 Apr;26(4):453-455. doi: 10.1038/s41591-020-0819-2.
6
Immune-epidemiological parameters of the novel coronavirus - a perspective.新型冠状病毒的免疫流行病学参数——一个视角。
Expert Rev Clin Immunol. 2020 May;16(5):465-470. doi: 10.1080/1744666X.2020.1750954. Epub 2020 Apr 6.
7
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
8
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.外周血中T细胞的疲惫水平升高和功能多样性降低可能预示着新冠病毒疾病(COVID-19)患者病情的严重进展。
Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.
9
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.